Skip to content

Maison Médicale Esseghem

Active Non-profit associationfounded 1982active for 44 yearsEsseghemstraat 24, 1090 JetteKBO/BCE: BE 0425.402.012 #6 oldest company in Jette, Health and social work sector

Lifetime

19 annual accounts with figures on one time axis, 20 filings since 2006
Gross marginpeak €2.1m (2018)
€2.1m▲ 17.3%
Resultpeak €191,262 (2021)
€129,858▲ 62.3%
Equitypeak €1.3m (2025)
€1.3m▲ 10.9%
Debts
€250,371▲ 3.8%
Staffpeak 20.1 FTE (2022)
19.5 FTE▲ 9.6%
Board12 names since 2021
5 directorsMugisha Ariane and 4 others
Documentsfilings and deeds
04-05-202688 days before the deadline
2025financial year
Gross margin from €1.8m to €2.1mResult from €79,998 to €129,858Staff from 17.8 FTE to 19.5 FTEInvestments €272,772

Key points

from the 2025 annual accounts

Equity

€1.3m ▲ 10.9%

Maison Médicale Esseghem has made a profit in every financial year since 2007.

Turnover

≈ €1.8m estimated

The accounts state no turnover.

Investments

€22,772 1.8 × depreciation
20212022202320242025

Green is investment, beige is depreciation.

Staff

24 employees on 31-12-2025
585520214443202231352023572024852025

In 2025, 8 people joined and 5 left.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

The last five annual accounts were filed 34 to 88 days before the end of the period.

Position in the sector

€2.1m

Higher gross margin than 89% of companies in human health. Sector median €497,372 · 727 companies.

Checked score

95
Excellent
Financially stronger than 58% of small companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 1,081 companies (NACE 86, small).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1%highest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

Solvency
93-4equity 67.6% of total assets
Liquidity
99+1short-term debt 12.1% · cash 68.6%
Profitability
77+2return on assets 6.7%

Score breakdown

lowers risk
Legal form: non-profit association
Liquidity: current ratio 6.90, cash €1.3m
Sector: Human health activities (NACE 86)
Equity €1.3m (67.6% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 44% of them on solvency, 92% on liquidity, 36% on profitability and 58% on growth.

The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 20,137 companies had the same profile as Maison Médicale Esseghem has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of Maison Médicale Esseghem itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,137 companies, not a prediction for Maison Médicale Esseghem. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €120,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 6.9 (7.2 in 2024), above the usual 1.5. Short-term debt is 12.1% and cash 68.6% of total assets. 32.4% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Legal form: non-profit association
KBO
lowers risk · Liquidity: current ratio 6.90, cash €1.3m
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €1.3m (67.6% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-05-2026, 88 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
88 days early
2024
70 days early
2023
65 days early
2022
34 days early
2021
38 days early
2020
25 days early
2019
23 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 49 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 May (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

GE
Director, since 27-03-2024
LJ
Director, since 27-03-2024
MA
Director
PB
Director, since 27-03-2024
Board & ownership

Recent changes

3 directors appointed, 3 resignations, 2 reappointments Resignations: Damrongrajasak Kita (director and chair), Wincq Michaël and Verbeeren Bernadette (secretary) · Reappointments: Mugisha Ariane (director and treasurer) and Verbeeren Bernadette · Appointments: Ghesquière Emmanuel (director and chair), Legros Joseph (director and secretary) and Peterkenne Bénédicte · General meeting of 27-03-2024 · Gazette deed
Amendment of the articles General meeting of 19-12-2023 · Gazette deed
3 directors appointed, 5 resignations, 1 reappointment Resignations: Meeus Philippe, Delattre Harry, Dupont Philippe, Poncin Daniel and Cavas Meryem · Reappointment: Damrongrajasak Kita · Appointments: Verbeeren Bernadette, Mugisha Ariane and Wincq Michaël · General meeting of 20-04-2021 · Gazette deed
First establishment Maison Médicale Esseghem-Jette, Esseghemstraat 24, Jette
All 31 events

Comparable companies

same main activity, similar in size and age
Company Turnover EBIT margin Solvency Staff
Maison Médicale Esseghem Jette - - 67.6% 19.5
MAISON MEDICALE SANTE PLURIELLE Sint-Gillis (bij-Brussel) €1.5m 10.4% 80.6% 19
Maison Médicale Le Noyer Schaerbeek - - 70.4% 15.6
AQUARELLE Grâce-Hollogne - - 85.0% 17.4
MAISON MEDICALE HERMA ASBL Liège - - 85.5% 18.7
Groupe Médicis Woluwe-Saint-Pierre €4.4m 4.7% - 15.7
Geneeskunde voor het Volk - Zelzate Zelzate - - 84.3% 23.1

These companies have the same main activity as Maison Médicale Esseghem: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.3m and €2.3m, founded between 1976 and 1996.

Official details

Source: KBO
Status
Active since 25-10-1982Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.160.475.0601090 Jette, since 25-10-1982
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

Total assets
€1.9m▲ 17.6%
Employeeson 31-12-2025
24▲ 14.3%
Filing
Filed on 04-05-2026, 88 days before the end of the filing period
Financials

Insights on Maison Médicale Esseghem

Maison Médicale Esseghem has existed since 1982. The gross margin grew from €861,659 in 2007 to €2.1m in 2025 and staff from 13 to 19.5 full-time equivalents.

The gross margin has grown every year since 2021.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Maison Médicale Esseghem

What is the company number of Maison Médicale Esseghem?
The company number of Maison Médicale Esseghem is 0425.402.012. The VAT number is the same number with BE in front: BE 0425.402.012.
Where is Maison Médicale Esseghem based?
The registered office is at Esseghemstraat 24, 1090 Jette.Company details
What does Maison Médicale Esseghem do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Maison Médicale Esseghem?
Maison Médicale Esseghem is a non-profit association (VZW).
When was Maison Médicale Esseghem founded?
Maison Médicale Esseghem was founded on 25-10-1982.
Is Maison Médicale Esseghem still active?
Yes, Maison Médicale Esseghem is an active enterprise in the KBO register.
How many employees does Maison Médicale Esseghem have?
Maison Médicale Esseghem had an average of 19.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Maison Médicale Esseghem?
The turnover in financial year 2025 is ≈ €1.8m. This figure is estimated from the gross margin of €2.1m and 64 comparable companies (NACE 86). It probably lies between €1.7m and €2.7m.
Is Maison Médicale Esseghem profitable?
In financial year 2025, Maison Médicale Esseghem made a profit of €129,858.
Where can I find the annual accounts of Maison Médicale Esseghem?
Maison Médicale Esseghem filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Maison Médicale Esseghem due?
Maison Médicale Esseghem must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.